Recursion Pharmaceuticals-a logo

Recursion Pharmaceuticals-a Share Price Today

(NASDAQ: RXRX)

Recursion Pharmaceuticals-a share price is $6.68 & ₹574.37 as on 22 Mar 2025, 2.30 'hrs' IST

$6.68

0.2

(3.09%)

Market is closed - opens 7 PM, 24 Mar 2025

View live Recursion Pharmaceuticals-a share price in Dollar and Rupees. Guide to invest in Recursion Pharmaceuticals-a stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Recursion Pharmaceuticals-a, along with analyst recommendations, forecasts, and comprehensive financials.

Recursion Pharmaceuticals-a share price movements

  • Today's Low: $6.29
    Today's High: $6.72

    Day's Volatility :6.41%

  • 52 Weeks Low: $5.60
    52 Weeks High: $12.36

    52 Weeks Volatility :54.69%

Recursion Pharmaceuticals-a (RXRX) Returns

PeriodRecursion Pharmaceuticals-aSector (Health Care)Index (Russel 2000)
3 Months
-4.43%
5.7%
0.0%
6 Months
0.15%
-5.1%
0.0%
1 Year
-36.56%
0.8%
0.0%
3 Years
-3.75%
9.4%
-13.8%

Recursion Pharmaceuticals-a (RXRX) Key Statistics

in dollars & INR

Previous Close
$6.48
Open
$6.31
Today's High
$6.7215
Today's Low
$6.2905
Market Capitalization
$2.6B
Today's Volume
$17.8M
52 Week High
$12.36
52 Week Low
$5.6
Revenue TTM
$58.8M
EBITDA
$-442.5M
Earnings Per Share (EPS)
$-1.74
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-61.9%

How to invest in Recursion Pharmaceuticals-a Stock (RXRX) from India?

It is very easy for Indian residents to invest directly in Recursion Pharmaceuticals-a from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Recursion Pharmaceuticals-a stock in both Indian Rupees (INR) and US Dollars (USD). Search for Recursion Pharmaceuticals-a or RXRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Recursion Pharmaceuticals-a or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Recursion Pharmaceuticals-a shares which would translate to 0.129 fractional shares of Recursion Pharmaceuticals-a as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Recursion Pharmaceuticals-a, in just a few clicks!

Returns in Recursion Pharmaceuticals-a (RXRX) for Indian investors in Rupees

The Recursion Pharmaceuticals-a stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Recursion Pharmaceuticals-a investment value today

Current value as on today

₹66,631

Returns

₹33,369

(-33.37%)

Returns from Recursion Pharmaceuticals-a Stock

₹36,562 (-36.56%)

Dollar Returns

₹3,194 (+3.19%)

Indian investors sentiment towards Recursion Pharmaceuticals-a (RXRX)

-15.13%

Period: Feb 20, 2025 to Mar 22, 2025. Change in 30 Days versus previous period

Investment in Recursion Pharmaceuticals-a Shares from India has dropped by -15.13% over the past 30 days, indicating reduced transactional activity.

-38%

Period: Feb 20, 2025 to Mar 22, 2025. Change in 30 Days versus previous period

Search interest for Recursion Pharmaceuticals-a Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Recursion Pharmaceuticals-a

  • Vanguard Group Inc

    8.46%

  • ARK Investment Management LLC

    8.05%

  • Baillie Gifford & Co Limited.

    6.19%

  • BlackRock Inc

    5.83%

  • SoftBank Group Corp

    3.65%

  • Mubadala Investment Company PJSC

    3.23%

Analyst Recommendation on Recursion Pharmaceuticals-a

Buy

    53%Buy

    46%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Recursion Pharmaceuticals-a(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
6
6
6
Sell
0
0
0

Analyst Forecast on Recursion Pharmaceuticals-a Stock (RXRX)

What analysts predicted

Upside of 34.73%

Target:

$9.00

Current:

$6.68

Insights on Recursion Pharmaceuticals-a Stock (Ticker Symbol: RXRX)

  • Price Movement

    In the last 1 month, RXRX stock has moved down by -28.0%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 26.08M → 4.51M (in $), with an average decrease of 82.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -95.67M → -178.90M (in $), with an average decrease of 87.0% per quarter
  • RXRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 93.4% return, outperforming this stock by 129.7%
  • RXRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 74.5% return, outperforming this stock by 77.8%
  • Price to Sales

    ForRXRX every $1 of sales, investors are willing to pay $31.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.1 for every $1 of sales.

Recursion Pharmaceuticals-a Technicals Summary

Sell

Neutral

Buy

Recursion Pharmaceuticals-a is currently in a neutral trading position according to technical analysis indicators.

Recursion Pharmaceuticals-a (RXRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Recursion Pharmaceuticals-a logo
-28.02%
0.15%
-36.56%
-3.75%
-76.54%
Regeneron Pharmaceuticals, Inc. logo
-5.98%
-39.7%
-31.49%
-3.13%
46.48%
Beone Medicines Ltd logo
-1.33%
25.17%
63.71%
24.48%
94.93%
Vertex Pharmaceuticals Incorporated logo
3.92%
9.39%
20.95%
99.92%
125.52%
Alnylam Pharmaceuticals, Inc. logo
13.07%
4.23%
86.32%
73.08%
183.51%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Recursion Pharmaceuticals-a logo
NA
NA
NA
-1.64
-0.62
-0.28
NA
2.61
Regeneron Pharmaceuticals, Inc. logo
17.27
17.27
0.98
42.64
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.45
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.43
18.06
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.71
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Recursion Pharmaceuticals-a logo
Buy
$2.6B
-76.54%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$72.4B
46.48%
17.27
31.07%
Beone Medicines Ltd logo
NA
$29.6B
94.93%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$131.0B
125.52%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$36.7B
183.51%
NA
-12.37%

Recursion Pharmaceuticals-a Dividend announcements

  • Recursion Pharmaceuticals-a Earnings

    Recursion Pharmaceuticals-a’s price-to-earnings ratio stands at None

About Recursion Pharmaceuticals-a

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Organization
Recursion Pharmaceuticals-a
Employees
800
CEO
Dr. Christopher C. Gibson Ph.D.
Industry
Services

Management People of Recursion Pharmaceuticals-a

NameTitle
Dr. Christopher C. Gibson Ph.D.
Co-Founder, CEO & Director
Dr. Dean Y. Li M.D., Ph.D.
Co-Founder & Independent Director
Dr. Blake C. Borgeson Ph.D.
Co-Founder & Director
Dr. David J. Mauro M.D., Ph.D.
Chief Medical Officer
Mr. Ben R. Taylor
CFO & President of Recursion UK
Ms. Kristen Rushton M.B.A.
Chief Operating Officer
Kevin Leggat
Vice President of Finance & Accounting
Mr. Benjamin Mabey M.S.
Chief Technology Officer
Dr. David Hallett Ph.D.
Chief Scientific Officer
Mr. Nathan Hatfield J.D., M.B.A.
Chief Legal Officer & General Counsel

Important FAQs about investing in RXRX Stock from India :

What is Recursion Pharmaceuticals-a share price today?

Recursion Pharmaceuticals-a share price today stands at $6.68, Open: $6.31 ; Previous Close: $6.48 ; High: $6.72 ; Low: $6.29 ; 52 Week High: $12.36 ; 52 Week Low: $5.60.

The stock opens at $6.31, after a previous close of $6.48. The stock reached a daily high of $6.72 and a low of $6.29, with a 52-week high of $12.36 and a 52-week low of $5.60.

Can Indians buy Recursion Pharmaceuticals-a shares?

Yes, Indians can invest in the Recursion Pharmaceuticals-a (RXRX) from India.

With INDmoney, you can buy Recursion Pharmaceuticals-a at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Recursion Pharmaceuticals-a at zero transaction cost.

How can I buy Recursion Pharmaceuticals-a shares from India?

It is very easy to buy Recursion Pharmaceuticals-a from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Recursion Pharmaceuticals-a (RXRX) be purchased?

Yes, you can buy fractional shares of Recursion Pharmaceuticals-a with INDmoney app.

What are the documents required to start investing in Recursion Pharmaceuticals-a stocks?

To start investing in Recursion Pharmaceuticals-a, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Recursion Pharmaceuticals-a Stock (RXRX)?

Today’s highest price of Recursion Pharmaceuticals-a (RXRX) is $6.72.

Today’s lowest price of Recursion Pharmaceuticals-a (RXRX) is $6.29.

What is today's market capitalisation of Recursion Pharmaceuticals-a?

Today's market capitalisation of Recursion Pharmaceuticals-a RXRX is 2.6B

What is the 52 Week High and Low Range of Recursion Pharmaceuticals-a Stock (RXRX)?

  • 52 Week High

    $12.36

  • 52 Week Low

    $5.60

What are the historical returns of Recursion Pharmaceuticals-a (RXRX)?

  • 1 Month Returns

    -28.02%

  • 3 Months Returns

    0.15%

  • 1 Year Returns

    -36.56%

  • 5 Years Returns

    -76.54%

Who is the Chief Executive Officer (CEO) of Recursion Pharmaceuticals-a ?

Dr. Christopher C. Gibson Ph.D. is the current Chief Executive Officer (CEO) of Recursion Pharmaceuticals-a.